Higher Risk of Treatment Failure With Vedolizumab Compared to TNF Antagonists for Older IBD Patients - MD Magazine
Vedolizumab was linked to an increased risk of treatment failure compared to TNF antagonists.
A new comparative analysis shows older patients with inflammatory bowel disease (IBD) treated with tumor necrosis factor (TNF) antagonists are less likely to suffer from treatment failure compared to… [+3190 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
